Literature DB >> 10193955

Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group.

M J Coppes1, M Arnold, J B Beckwith, M L Ritchey, G J D'Angio, D M Green, N E Breslow.   

Abstract

BACKGROUND: Approximately 1% of children with unilateral Wilms tumor develop contralateral disease. The authors assessed the demographic and histologic features associated with metachronous bilateral Wilms tumor (BWT).
METHODS: Characteristics of all children registered on the first four National Wilms Tumor Studies (NWTS) were recorded. The primary endpoint for evaluation was the first appearance of Wilms tumor in the remaining kidney. The cumulative risk of contralateral disease as a function of time since initial presentation was calculated as 1 minus the Kaplan-Meier estimate of remaining free of contralateral disease. A matched case control study was conducted to determine whether the presence and type of nephrogenic rests (NRs) were associated with metachronous BWT.
RESULTS: Fifty-eight of 4669 registered children developed metachronous BWT; 38 of 2445 females (expected, 30.2) versus 20 of 2224 males (expected, 27.8) (P = 0.04) developed BWT. The cumulative incidence of contralateral disease 6 years after initial diagnosis decreased from greater than 3% in the first NWTS to approximately 1.5% in the three subsequent studies (P = 0.08). Patients with NRs had a significantly increased risk of metachronous BWT. This was particularly true for young children (20 of 206 age < 12 months compared with 0 of 304 age > 12 months). Data from the matched case control study confirmed the increased relative risk associated with young age and the presence of NRs.
CONCLUSIONS: Children younger than 12 months diagnosed with Wilms tumor who also have NRs, in particular perilobar NRs, have a markedly increased risk of developing contralateral disease and require frequent and regular surveillance for several years. Surveillance is also recommended for those with NRs who are diagnosed after the age of 12 months.

Entities:  

Mesh:

Year:  1999        PMID: 10193955     DOI: 10.1002/(sici)1097-0142(19990401)85:7<1616::aid-cncr26>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Wilms tumor: what's new?

Authors:  Tomás Acha García; Carlota Calvo Escribano; José Alfaro Gutiérrez; Paloma Galarón García; Mercedes Guibelalde del Castillo
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405

3.  Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.

Authors:  Conrad V Fernandez; Elizabeth J Perlman; Elizabeth A Mullen; Yueh-Yun Chi; Thomas E Hamilton; Kenneth W Gow; Fernando A Ferrer; Douglas C Barnhart; Peter F Ehrlich; Geetika Khanna; John A Kalapurakal; Tina Bocking; Vicky Huff; Jing Tian; James I Geller; Paul E Grundy; James R Anderson; Jeffrey S Dome; Robert C Shamberger
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

Review 4.  Silver-Russell Syndrome and Beckwith-Wiedemann Syndrome: Opposite Phenotypes with Heterogeneous Molecular Etiology.

Authors:  Katrin Õunap
Journal:  Mol Syndromol       Date:  2016-07-06

Review 5.  Management of bilateral Wilms tumours.

Authors:  Alastair J W Millar; Sharon Cox; Alan Davidson
Journal:  Pediatr Surg Int       Date:  2017-05-17       Impact factor: 1.827

6.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

7.  Bilateral disease and new trends in Wilms tumour.

Authors:  Catherine M Owens; Hervé J Brisse; Øystein E Olsen; Joanna Begent; Anne M Smets
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 8.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 9.  Imaging in unilateral Wilms tumour.

Authors:  Hervé J Brisse; Anne M Smets; Sue C Kaste; Catherine M Owens
Journal:  Pediatr Radiol       Date:  2007-11-16

10.  Wilms' tumor: An update.

Authors:  Hemant B Tongaonkar; Sajid S Qureshi; Purna A Kurkure; Mary-Ann A Muckaden; Brijesh Arora; Thyavihalli B Yuvaraja
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.